Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology.

Literature DB >> 26692196

Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology.

Abstract

Human mesenchymal stromal/stem cells (MSCs) have capabilities for multi-differentiation, immunomodulation, and hematopoietic support. Based on these unique biological characteristics, human MSCs have been extensively used as a transplantable resource for cell therapy in regenerative medicine, immune diseases, and hematological diseases. One of the most promising therapeutic effects of human MSCs is in hematopoietic stem cell transplantation for acute graft-versus-host disease (GVHD). Off-the-shelf MSC products are approved by regulatory agencies in some countries. In Japan, hematologists may soon have the option to use these products for the treatment of intractable acute GVHD. This review provides a brief overview of human MSCs including their fundamental characteristics, their clinical applications, and perspectives.

Entities: Disease Species

Keywords: Clinical application; Hematopoiesis; Human mesenchymal stromal/stem cells

Mesh：

Year: 2015 PMID： 26692196 DOI： 10.1007/s12185-015-1920-z

Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490

29 in total

1. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors: Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal: Lancet Date: 2004-05-01 Impact factor: 79.321

2. Development of mesenchymal stem cells partially originate from the neural crest.

Authors: Satoru Morikawa; Yo Mabuchi; Kunimichi Niibe; Sadafumi Suzuki; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Yasuo Nagai; Taneaki Nakagawa; Hideyuki Okano; Yumi Matsuzaki
Journal: Biochem Biophys Res Commun Date: 2009-01-20 Impact factor: 3.575

3. Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system.

Authors: Satoshi Yoshioka; Yasuo Miura; Masaki Iwasa; Aya Fujishiro; Hisayuki Yao; Masako Miura; Masaaki Fukuoka; Yoko Nakagawa; Asumi Yokota; Hideyo Hirai; Tatsuo Ichinohe; Akifumi Takaori-Kondo; Taira Maekawa
Journal: Int J Hematol Date: 2015-06-30 Impact factor: 2.490

4. Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients.

Authors: Mats Remberger; Olle Ringdén
Journal: Int J Hematol Date: 2012-11-11 Impact factor: 2.490

5. Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Authors: Marcos de Lima; Ian McNiece; Simon N Robinson; Mark Munsell; Mary Eapen; Mary Horowitz; Amin Alousi; Rima Saliba; John D McMannis; Indreshpal Kaur; Partow Kebriaei; Simrit Parmar; Uday Popat; Chitra Hosing; Richard Champlin; Catherine Bollard; Jeffrey J Molldrem; Roy B Jones; Yago Nieto; Borje S Andersson; Nina Shah; Betul Oran; Laurence J N Cooper; Laura Worth; Muzaffar H Qazilbash; Martin Korbling; Gabriela Rondon; Stefan Ciurea; Doyle Bosque; Ila Maewal; Paul J Simmons; Elizabeth J Shpall
Journal: N Engl J Med Date: 2012-12-13 Impact factor: 91.245

6. CCAAT/enhancer-binding protein β expressed by bone marrow mesenchymal stromal cells regulates early B-cell lymphopoiesis.

Authors: Satoshi Yoshioka; Yasuo Miura; Hisayuki Yao; Sakiko Satake; Yoshihiro Hayashi; Akihiro Tamura; Terutoshi Hishita; Tatsuo Ichinohe; Hideyo Hirai; Akifumi Takaor-Kondo; Taira Maekawa
Journal: Stem Cells Date: 2014-03 Impact factor: 6.277

7. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

Authors: Hillard M Lazarus; Omer N Koc; Steven M Devine; Peter Curtin; Richard T Maziarz; H Kent Holland; Elizabeth J Shpall; Philip McCarthy; Kerry Atkinson; Brenda W Cooper; Stanton L Gerson; Mary J Laughlin; Fausto R Loberiza; Annemarie B Moseley; Andrea Bacigalupo
Journal: Biol Blood Marrow Transplant Date: 2005-05 Impact factor: 5.742

8. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.

Authors: M L Macmillan; B R Blazar; T E DeFor; J E Wagner
Journal: Bone Marrow Transplant Date: 2008-10-27 Impact factor: 5.483

9. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.

Authors: H M Lazarus; S E Haynesworth; S L Gerson; N S Rosenthal; A I Caplan
Journal: Bone Marrow Transplant Date: 1995-10 Impact factor: 5.483

10. Parathyroid hormone enhances hematopoietic expansion via upregulation of cadherin-11 in bone marrow mesenchymal stromal cells.

Authors: Hisayuki Yao; Yasuo Miura; Satoshi Yoshioka; Masako Miura; Yoshihiro Hayashi; Akihiro Tamura; Masaki Iwasa; Atsushi Sato; Terutoshi Hishita; Yayoi Higashi; Hitomi Kaneko; Eishi Ashihara; Tatsuo Ichinohe; Hideyo Hirai; Taira Maekawa
Journal: Stem Cells Date: 2014-08 Impact factor: 6.277

24 in total

1. Guest editorial: Human mesenchymal stromal/stem cell (MSC).

Authors: Yasuo Miura
Journal: Int J Hematol Date: 2015-12-23 Impact factor: 2.490

2. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.

Authors: Masaki Iwasa; Yasuo Miura; Aya Fujishiro; Sumie Fujii; Noriko Sugino; Satoshi Yoshioka; Asumi Yokota; Terutoshi Hishita; Hideyo Hirai; Akira Andoh; Tatsuo Ichinohe; Taira Maekawa
Journal: Int J Hematol Date: 2017-01-02 Impact factor: 2.490

3. Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.

Authors: L A Kuzmina; N A Petinati; N V Sats; N J Drize; N V Risinskaya; A B Sudarikov; V A Vasilieva; M Y Drokov; E D Michalzova; E N Parovichnikova; V G Savchenko
Journal: Int J Hematol Date: 2016-05-12 Impact factor: 2.490

Review 4. Extracellular vesicles and blood diseases.

Authors: Shosaku Nomura
Journal: Int J Hematol Date: 2017-01-27 Impact factor: 2.490

Review 5. Chemical and Physical Approaches to Extend the Replicative and Differentiation Potential of Stem Cells.

Authors: Eun Seong Hwang; Jeong Soo Ok; SeonBeom Song
Journal: Stem Cell Rev Rep Date: 2016-06 Impact factor: 5.739

6. Impact of donor characteristics on the quality of bone marrow as a source of mesenchymal stromal cells.

Authors: Emilia Barreto-Durán; Claudia Camila Mejía-Cruz; Efrain Leal-García; Rafael Pérez-Núñez; Viviana Marcela Rodríguez-Pardo
Journal: Am J Stem Cells Date: 2018-12-01

7. Phenotypic and Functional Characterizations of Mesenchymal Stem/Stromal Cells Isolated From Human Cranial Bone Marrow.

Authors: Kaichuang Yang; Ruijie Lu; Jianan Lu; Shucai Fan; Qiang Zhang; Zijian Lou; Yuyuan Ma; Gang Lu; Ruolang Pan; Jianmin Zhang
Journal: Front Neurosci Date: 2022-06-07 Impact factor: 5.152